Though recent data shows a meaningful decrease in the U.S. adult obesity rate (37 percent in 2025 compared with a record high of 39.9 percent in 2022), the need for obesity treatments is still ...
Hosted on MSN
Wegovy pill launch promises change — but its cost and what it does could decide who gets help
The launch of the Wegovy pill is being hailed as a turning point in obesity treatment, offering the first tablet version of a drug that has already reshaped the global weight-loss market. Approved ...
With the U.S. Food and Drug Administration (FDA) recently approving GLP-1 drug Wegovy in pill form for use in weight loss and fighting obesity, the question arises whether other GLP-1 drugs will also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results